Stay updated on NSCLC Neoadjuvant Combo Clinical Trial

Sign up to get notified when there's something new on the NSCLC Neoadjuvant Combo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NSCLC Neoadjuvant Combo Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. No clinical content or study data is affected.
    Difference
    0.0%
    Check dated 2026-03-11T23:49:25.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government funding operating-status notice; the primary study information and plan remain unchanged.
    Difference
    0.2%
    Check dated 2026-02-11T12:41:20.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and operating status was added, and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T06:49:45.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata labels (Last Update Submitted that Met QC Criteria, Last Update Posted) along with the page revision indicator (Revision: v3.4.0). Adjustments were also made to capitalization and labels for No FEAR Act data.
    Difference
    0.1%
    Check dated 2026-01-28T04:48:16.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page displays a new label 'Last Update Posted (Estimated)' and a new revision tag 'Revision: v3.3.4'. The previous labels 'Last Update Posted' and 'Revision: v3.3.3' have been removed.
    Difference
    0.0%
    Check dated 2026-01-14T02:42:05.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Locations updated to 138 (from 140); Overall Survival follow-up is now listed as up to approximately 93 months and TTDM follow-up as up to approximately 84 months.
    Difference
    0.3%
    Check dated 2026-01-07T00:37:49.000Z thumbnail image

Stay in the know with updates to NSCLC Neoadjuvant Combo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NSCLC Neoadjuvant Combo Clinical Trial page.